INCR
Income statement / Annual
Last year (2023), InterCure Ltd.'s total revenue was $355.55 M,
a decrease of 8.52% from the previous year.
In 2023, InterCure Ltd.'s net income was -$61.96 M.
See InterCure Ltd.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$355.55 M
|
$388.68 M
|
$219.68 M
|
$65.04 M
|
$8.93 M
|
$0.00
|
$0.00
|
$0.00
|
$1.40 M
|
$5.65 M
|
Cost of Revenue |
$250.46 M |
$233.60 M |
$128.55 M |
$33.06 M |
$7.45 M |
$0.00 |
$0.00 |
$0.00 |
$538,705.00 |
$1.87 M |
Gross Profit |
$105.10 M |
$155.08 M |
$91.13 M |
$31.98 M |
$1.48 M |
$0.00 |
$0.00 |
$0.00 |
$862,708.00 |
$3.78 M |
Gross Profit Ratio |
0.3 |
0.4 |
0.41 |
0.49 |
0.17 |
0 |
0 |
0 |
0.62 |
0.67 |
Research and Development
Expenses |
$388,000.00
|
$632,000.00
|
$1.24 M
|
$1.58 M
|
$1.71 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$50,621.00
|
General & Administrative
Expenses |
$64.30 M
|
$91.72 M
|
$30.73 M
|
$17.86 M
|
$76.36 M
|
$9.81 M
|
$1.12 M
|
$1.40 M
|
$2.02 M
|
$3.17 M
|
Selling & Marketing
Expenses |
$21.94 M
|
$5.60 M
|
$23.21 M
|
$8.44 M
|
$2.69 M
|
$0.00
|
$0.00
|
$0.00
|
$167,857.00
|
$2.54 M
|
Selling, General &
Administrative Expenses |
$86.24 M
|
$97.32 M
|
$53.94 M
|
$26.30 M
|
$79.05 M
|
$9.81 M
|
$1.12 M
|
$1.40 M
|
$2.19 M
|
$5.71 M
|
Other Expenses |
-$7.41 M |
$4.20 M |
$2.93 M |
$745,000.00 |
$853,000.00 |
$0.00 |
$24,329.00 |
$369,273.00 |
$89,784.00 |
$140,181.00 |
Operating Expenses |
$67.50 M |
$102.15 M |
$58.11 M |
$28.62 M |
$81.62 M |
$9.81 M |
$1.12 M |
$1.40 M |
$2.39 M |
$5.90 M |
Cost And Expenses |
$317.96 M |
$335.76 M |
$186.65 M |
$61.68 M |
$89.06 M |
$9.81 M |
$1.12 M |
$1.40 M |
$2.92 M |
$7.77 M |
Interest Income |
$5.38 M |
$844,000.00 |
$130,000.00 |
$21,000.00 |
$141,000.00 |
$0.00 |
$0.00 |
$0.00 |
$19,518.00 |
$0.00 |
Interest Expense |
$24.22 M |
$14.69 M |
$5.05 M |
$264,000.00 |
$1.84 M |
$1.03 M |
$639,510.00 |
$411,586.00 |
-$206,893.98 |
-$109,030.04 |
Depreciation &
Amortization |
$13.17 M
|
$11.70 M
|
$7.39 M
|
$3.25 M
|
$23,000.00
|
$10,000.00
|
$4,000.00
|
$979,000.00
|
$870,516.00
|
$23,363.00
|
EBITDA |
$46.57 M
|
$64.50 M
|
$37.58 M
|
$1.81 M
|
-$21.20 M
|
-$8.16 M
|
-$1.09 M
|
-$1.07 M
|
-$1.64 M
|
-$2.21 M
|
EBITDA Ratio |
0.13 |
0.17 |
0.17 |
0.03 |
-2.38 |
0 |
0 |
0 |
-1.17 |
-0.39 |
Operating Income Ratio
|
-0.12
|
0.14
|
0.13
|
-0.02
|
-8.98
|
0
|
0
|
0
|
-1.79
|
0.47
|
Total Other
Income/Expenses Net |
-$77.88 M
|
-$8.96 M
|
-$9.45 M
|
-$36.86 M
|
$76.47 M
|
-$1.95 M
|
-$3.50 M
|
$2.12 M
|
-$148,339.08
|
-$1.56 M
|
Income Before Tax |
-$61.29 M |
$43.84 M |
$18.74 M |
-$38.31 M |
-$3.67 M |
-$12.80 M |
-$5.26 M |
$265,415.00 |
-$1.88 M |
-$3.79 M |
Income Before Tax Ratio
|
-0.17
|
0.11
|
0.09
|
-0.59
|
-0.41
|
0
|
0
|
0
|
-1.34
|
-0.67
|
Income Tax Expense |
$2.25 M |
$93,000.00 |
$11.44 M |
-$2.27 M |
-$673,000.00 |
-$1.15 M |
$663,839.00 |
$3.05 M |
-$780,732.00 |
-$0.00 |
Net Income |
-$61.96 M |
$44.82 M |
$7.30 M |
-$36.04 M |
-$3.00 M |
-$12.80 M |
-$5.26 M |
$265,415.00 |
-$1.88 M |
-$3.79 M |
Net Income Ratio |
-0.17 |
0.12 |
0.03 |
-0.55 |
-0.34 |
0 |
0 |
0 |
-1.34 |
-0.67 |
EPS |
-1.36 |
0.99 |
0.16 |
-1.42 |
-0.13 |
-0.62 |
-0.31 |
0.0211 |
-0.21 |
-2.34 |
EPS Diluted |
-1.36 |
0.99 |
0.16 |
-1.42 |
-0.13 |
-0.62 |
-0.31 |
0.0206 |
-0.21 |
-2.34 |
Weighted Average Shares
Out |
$45.56 M
|
$45.35 M
|
$46.92 M
|
$25.40 M
|
$23.30 M
|
$20.60 M
|
$16.78 M
|
$12.58 M
|
$8.85 M
|
$1.62 M
|
Weighted Average Shares
Out Diluted |
$45.56 M
|
$45.35 M
|
$46.92 M
|
$25.40 M
|
$23.30 M
|
$20.60 M
|
$17.11 M
|
$12.90 M
|
$8.85 M
|
$1.62 M
|
Link |
|
|
|
|
|
|
|
|
|
|